Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113045539B discloses a mild, high-yield synthesis of 2-(4,4-dichloro-1-(8-quinolyl)-2-azetidinyl) esters, offering significant cost reduction in API manufacturing.
Patent CN104418784B details a novel resolution method for antiviral intermediates. Achieve high de% purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN119661412A reveals a high-yield synthesis route for Upadacitinib intermediates, offering significant cost reduction and scalable manufacturing solutions for global supply chains.
Patent CN113117753B introduces a hydrophobic catalyst for high-yield beta-ionone production, eliminating sulfuric acid waste and enabling mild reaction conditions.
Patent CN104876995B details a 5-step Swern oxidation route for 6ECDCA. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Novel copper-catalyzed method for 2-phenylthiobenzoic acid production. High yield, scalable, eco-friendly pharmaceutical intermediate supply chain solution for global buyers.
Novel patent CN119552143A details high-yield dapagliflozin intermediate synthesis. Reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN110669002A reveals a novel two-step synthesis for 2-fluoro-3-hydroxypyridine-4-carboxylic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Novel copper-catalyzed coupling route for high-purity 4,4'-diphenyl ether dicarboxylic acid. Reduces waste and improves yield for polymer monomers.
Patent CN119638597B reveals optimized synthesis reducing salt and solvent. Enhances supply chain reliability for agrochemical intermediate manufacturing globally.
Patent CN111123645A discloses a novel cedrol-based sulfonium salt PAG that reduces acid diffusion and edge roughness in chemically amplified resists for advanced IC manufacturing.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Advanced patent CN106478518A enables high-purity Rosuvastatin intermediate production with improved safety and scalability for global supply chains.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109824553B details a mild, high-yield synthesis of 2-((tert-butoxycarbonyl)amino)ethyl-1-sulfonic acid. Discover cost-effective strategies for pharma manufacturing.
Patent CN114525529B reveals a green electrochemical route for thio(seleno)phosphoric acid thioesters, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Efficient synthesis of 5-(trifluoromethoxy)-1H-benzo[d]imidazole-2-carboxylic acid via iron reduction and permanganate oxidation. Ideal for API intermediates.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN110483388A reveals high-yield synthesis for nicotinic acid derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.